Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Chemmedchem|May 1, 2015
Multitarget Therapeutic Leads for Alzheimer's Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) AggregationMichele Tonelli, Marco Catto, Bruno Tasso, et al.Plos One|May 5, 2012
A chemocentric approach to the identification of cancer targetsBeáta Flachner, Zsolt Lörincz, Angelo Carotti, et al.Journal of Medicinal Chemistry|October 9, 2009
Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitorLeonardo Pisani, Giovanni Muncipinto, Teresa Fabiola Miscioscia, et al.Journal of Computer-Aided Molecular Design|June 27, 2003
Distant collaboration in drug discovery: the LINK3D projectManuel Pastor, Paolo Benedetti, Angelo Carotti, et al.Molecular Informatics|August 23, 2016
Mind the Gap! A Journey towards Computational ToxicologyGiuseppe Felice Mangiatordi, Domenico Alberga, Cosimo Damiano Altomare, et al.Journal of Medicinal Chemistry|June 28, 2016
Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget AgentsLeonardo Pisani, Roberta Farina, Marco Catto, et al.Journal of Chemical Information and Modeling|December 9, 2014
Computer-aided structure-based design of multitarget leads for Alzheimer's diseaseJosé L Domínguez, Fernando Fernández-Nieto, Marian Castro, et al.Bioorganic & Medicinal Chemistry Letters|February 13, 2017
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymesByeongyeon Park, Ji Hye Nam, Jin Han Kim, et al.Journal of Medicinal Chemistry|January 6, 2006
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptorAngelo Carotti, Maria Isabel Cadavid, Nuria B Centeno, et al.Bioorganic & Medicinal Chemistry|April 29, 2009
1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationshipsFranco Fernández, Olga Caamaño, M Isabel Nieto, et al.Pageof 9